Searchable abstracts of presentations at key conferences in endocrinology

ea0073yi6 | Young Investigator Awards | ECE2021

Unveiling the pathophysiological relationship between prostate cancer and obesity: miR-107 as a novel personalized diagnostic and therapeutic tool

Prudencio Sáez-Martínez , Vicente Herrero-Aguayo , Juan M. Jiménez-Vacas , Trinidad Moreno-Montilla , Julia Carrasco-Valiente , André Sarmento-Cabral , José López-Miranda , Enrique Gómez-Gómez , Manuel D. Gahete , Raúl M. Luque

Prostate cancer (PCa) is one of the most common causes of cancer-related deaths in men worldwide. Therefore, more specific and non-invasive diagnostic biomarkers as well as novel therapeutic targets are urgently needed. As miRNAs have been proposed as promising elements for the identification of novel diagnostic and therapeutic tools for different pathologies, including cancer, we investigated the miRNA landscape in PCa and explored their putative diagnostic/therapeutic utilit...

ea0073ep129 | Endocrine-Related Cancer | ECE2021

PRPF8 regulates FAK/AKT pathway and cytoskeleton remodeling through modulation of fibronectin 1 splicing in liver pathologies

Natalia Hermán-Sánchez , Juan L. López-Cánovas , Mercedes del Río-Moreno , Antonio C. Fuentes-Fayos , Marina E. Sánchez-Frias , Víctor Amado , Rubén Ciria , Javier Briceño , Manuel de la Mata , Justo P. Castaño , Manuel Rodríguez-Perálvarez , Raúl M. Luque , Manuel D. Gahete

Obesity is emerging as a prevalent cause of chronic liver damage, which can lead to the development of metabolic-associated fatty liver disease (MAFLD), nonalcoholic steatohepatitis (NASH), or even hepatocellular carcinoma (HCC). Increasing evidence suggests a profound dysregulation of the splicing machinery (spliceosome and splicing factors) in these pathologies; however, the role of PRPF8, a pivotal spliceosome element, has not been described in chronic liver pathologies. Th...